LYZ and infectious disease: Nevertheless, the use of lysozyme—a model protein rather than a pathogen‐specific vaccine—marks a limitation of this study, suggesting the need for further investigation into the comprehensive application of this NP‐based delivery system in addressing real‐world infectious diseases within translational medicine.